Viatris (VTRS) insider buying

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $19.0B

6 open-market purchases of VTRS by Viatris's executives and directors since May 2025, worth $761,382 in total, from SEC Form 4 filings.

The most recent: Gilbert Ray Cisneros, Jr. bought — on November 18, 2025.

The biggest buyer over the period is Scott Andrew Smith: 2 purchases, $756,180.

By year

YearPurchasesValue
20256$761,382

Biggest buyers

InsiderBuysValue
Scott Andrew Smith
2$756,180
David S Simmons
2$5,202
Gilbert Ray Cisneros, Jr.
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Nov 18, 2025 Gilbert Ray Cisneros, Jr.
0$10.71— —
Nov 18, 2025 Gilbert Ray Cisneros, Jr.
0$10.71— —
Nov 3, 2025 David S Simmons
213$10.43$2,222 Form 4
Aug 27, 2025 David S Simmons
286$10.42$2,980 Form 4
Aug 12, 2025 Scott Andrew Smith
22,000$9.99$219,780 Form 4
May 12, 2025 Scott Andrew Smith
60,000$8.94$536,400 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for VTRS.
Open VTRS in Investingly

Questions

Are Viatris insiders buying the stock?

6 open-market purchases of VTRS by Viatris's executives and directors since May 2025, worth $761,382 in total, from SEC Form 4 filings. The most recent: Gilbert Ray Cisneros, Jr. bought — on November 18, 2025.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Viatris's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.